Oleuropein aglycone and hydroxytyrosol interfere differently with toxic Aβ

Acrylamide (PubChem CID: 6579) Alzheimer's disease Amyloid Aβ(1-42) peptide Congo Red (PubChem CID: 11313) Hydroxythyrosol (PubChem: 82755) Dimethylsulfoxide (PubChem CID: 679) Hydroxytyrosol MTT (PubChem CID: 64965) N,N-dimethylformamide (PubChem CID: 6228) Oleuropein Aglycone (PubChem CID: 56842347) Oleuropein aglycone Sodium Dodecil Sulfate (PubChem CID: 3423265)

Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 04 01 2019
revised: 08 04 2019
accepted: 10 04 2019
pubmed: 18 4 2019
medline: 7 8 2019
entrez: 18 4 2019
Statut: ppublish

Résumé

Oleuropein aglycone (OleA), the most abundant polyphenol in extra virgin olive oil (EVOO), and Hydroxythyrosol (HT), the OleA main metabolite, have attracted our interest due to their multitarget effects, including the interference with amyloid aggregation path. However, the mechanistic details of their anti-amyloid effect are not known yet. We report here a broad biophysical approach and cell biology techniques that enabled us to characterize the different molecular mechanisms by which OleA and HT modulate the Aβ

Identifiants

pubmed: 30995514
pii: S0278-6915(19)30214-5
doi: 10.1016/j.fct.2019.04.015
pii:
doi:

Substances chimiques

Acetates 0
Amyloid beta-Peptides 0
Cyclopentane Monoterpenes 0
Peptide Fragments 0
Pyrans 0
amyloid beta-protein (1-42) 0
oleuropein aglycone 0
3,4-dihydroxyphenylethanol 10597-60-1
Phenylethyl Alcohol ML9LGA7468

Types de publication

Journal Article

Langues

eng

Pagination

1-12

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Manuela Leri (M)

Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', University of Florence, Viale Morgagni 50 - 50134, Florence, Italy; Department of Neuroscience, Psychology, Area of Medicine and Health of the Child of the University of Florence, Viale Pieraccini, 6 - 50139 Florence, Italy. Electronic address: manuela.leri@unifi.it.

Antonino Natalello (A)

Department of Biotechnology and Biosciences, University of Milano Bicocca, Piazza della Scienza 2, 20126, Milano, Italy. Electronic address: antonino.natalello@unimib.it.

Elena Bruzzone (E)

Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', University of Florence, Viale Morgagni 50 - 50134, Florence, Italy. Electronic address: elena.bruzzone@unifi.it.

Massimo Stefani (M)

Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', University of Florence, Viale Morgagni 50 - 50134, Florence, Italy; Interuniversity Center for the Study of Neurodegenerative Diseases (CIMN), Florence, Italy. Electronic address: massimo.stefani@unifi.it.

Monica Bucciantini (M)

Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio', University of Florence, Viale Morgagni 50 - 50134, Florence, Italy; Interuniversity Center for the Study of Neurodegenerative Diseases (CIMN), Florence, Italy. Electronic address: monica.bucciantini@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH